Mirati Therapeutics, Inc.
USD58.70
-0.10 (-0.17%)
CEO
Charles M. Baum
IPO Date
2013-07-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$58.86
Prev. Close
$58.80
Day Low
$58.54
Day High
$58.99
52W Low
$27.30
52W High
$64.41
Market Cap
$4.12B
Volume
20.96M
| -13.1 |
| 31 Dec 2020 | FY | -2134.3% | -2671.6% | -26.3% | -24.2% | 0.03 | 19.64 | -27.6 |
| 31 Dec 2019 | FY | -5383.2% | -6394.5% | -55.8% | -49.3% | 0.00 | 8.68 | -22.6 |
| 31 Dec 2018 | FY | -626.2% | -761.4% | -48.8% | -43.1% | 0.00 | 8.67 | -13.3 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -49.2% | -44.8% | 0.00 | 11.42 | -6.6 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -172.1% | -131.0% | 0.00 | 3.97 | -1.1 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -54.6% | -50.4% | 0.00 | 12.80 | -8.3 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | -155.7% | -130.5% | 0.00 | 6.05 | -5.7 |
| 31 Dec 2013 | FY | 0.0% | 0.0% | -204.3% | -81.9% | 0.00 | 1.66 | -3.5 |
| -3.0 |
| 31 Mar 2023 | Q1 | 88.6% | -2575.5% | -21.4% | -17.9% | 0.05 | 7.54 | -2.9 |
| 31 Dec 2022 | Q4 | -15085.9% | -21678.3% | -20.3% | -16.8% | 0.05 | 6.96 | -3.2 |
| 30 Sept 2022 | Q3 | -2313.5% | -3195.7% | -15.4% | -13.3% | 0.05 | 9.65 | -5.7 |
| 30 Jun 2022 | Q2 | -2293.5% | -3290.7% | -15.9% | -13.8% | 0.05 | 10.10 | -5.3 |
| 31 Mar 2022 | Q1 | -18373.3% | -26570.7% | -15.1% | -13.3% | 0.04 | 10.87 | -6.0 |
| 31 Dec 2021 | Q4 | -51351.2% | -66938.8% | -14.3% | -12.6% | 0.03 | 10.50 | -9.8 |
| 30 Sept 2021 | Q3 | -61.7% | -111.5% | -7.4% | -6.4% | 0.04 | 9.60 | -28.5 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -14.7% | -12.3% | 0.04 | 7.07 | -12.5 |